tiprankstipranks
Advertisement

FLGB - ETF AI Analysis

Compare

Top Page

FLGB

Franklin FTSE United Kingdom ETF (FLGB)

Rating:72Outperform
Price Target:
FLGB, the Franklin FTSE United Kingdom ETF, has a solid overall rating, helped by strong core holdings like AstraZeneca, HSBC, and Rio Tinto, which benefit from healthy financial performance, supportive valuations, and positive strategic moves. Some holdings such as Shell, Unilever, Rolls-Royce, BP, and BAE Systems face issues like short-term technical weakness, high valuations, or financial stability concerns, which slightly weigh on the fund’s rating. A key risk factor is the ETF’s concentration in a single country (the UK), meaning its performance is closely tied to the health of the UK market and economy.
Positive Factors
Strong Recent Performance
The ETF has shown solid gains so far this year and in recent months, indicating positive momentum in its holdings.
Leading UK Blue-Chip Holdings
Many of the largest positions, such as major banks, energy companies, and defense contractors, have delivered strong performance, helping drive the fund’s returns.
Low Expense Ratio
The fund charges a relatively low fee, which helps investors keep more of their returns over time.
Negative Factors
Heavy UK Concentration
With most assets invested in the UK, the ETF is highly exposed to the health of the British economy and its currency.
Sector Concentration in Financials and Energy
A large share of the portfolio is in financial and energy stocks, which can make the fund more sensitive to interest rate changes and commodity price swings.
Some Weak Top Holdings
A few major positions, such as certain consumer defensive names, have shown weak performance, which can drag on overall returns if the trend continues.

FLGB vs. SPDR S&P 500 ETF (SPY)

FLGB Summary

The Franklin FTSE United Kingdom ETF (FLGB) tracks the FTSE UK RIC Capped Index, giving you broad exposure to the overall UK stock market in a single investment. It holds many types of companies, from banks and energy firms to healthcare and consumer brands. Well-known holdings include HSBC and AstraZeneca. Someone might invest in FLGB to diversify outside the U.S. and to spread their money across many sectors of the UK economy. A key risk is that the fund’s value can rise or fall with the UK stock market and the British economy.
How much will it cost me?The Franklin FTSE United Kingdom ETF (FLGB) has an expense ratio of 0.09%, which means you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs down.
What would affect this ETF?The Franklin FTSE United Kingdom ETF (FLGB) could benefit from positive trends in the UK economy, such as growth in the financial and healthcare sectors, which are heavily weighted in the fund. However, potential risks include economic uncertainty due to interest rate changes, energy price volatility affecting holdings like Shell and BP, and regulatory shifts impacting major industries like financials and consumer goods. Investors should also consider how broader European economic conditions might influence the ETF's performance.

FLGB Top 10 Holdings

FLGB leans heavily into big U.K. financials and defensives, with HSBC setting the pace as a rising heavyweight and health-care names like AstraZeneca and GSK providing steady, supportive lift. Energy is another key engine: BP is powering ahead, while Shell’s more mixed pattern adds a bit of wobble to the ride. On the flip side, consumer staple giant Unilever is losing steam and tugging on returns, with British American Tobacco also lagging. Overall, this is a distinctly U.K.-centric play, driven by banks, pharma, and energy rather than high-flying tech.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
HSBC Holdings9.29%$78.15M£226.99B58.35%
80
Outperform
AstraZeneca8.58%$72.18M$292.69B32.74%
80
Outperform
Shell (UK)7.58%$63.82M£184.86B32.32%
73
Outperform
Rolls-Royce Holdings3.93%$33.05M£94.80B52.14%
71
Outperform
Unilever3.71%$31.25M£93.54B
72
Outperform
BP p.l.c.3.68%$30.94M£88.37B58.12%
71
Outperform
British American Tobacco3.65%$30.73M£93.11B34.43%
71
Outperform
GlaxoSmithKline3.30%$27.77M£80.64B43.08%
77
Outperform
Rio Tinto3.11%$26.20M£126.33B62.36%
82
Outperform
National Grid2.62%$22.08M£64.41B20.67%
76
Outperform

FLGB Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
35.61
Negative
100DMA
34.99
Positive
200DMA
33.24
Positive
Market Momentum
MACD
0.10
Positive
RSI
42.55
Neutral
STOCH
6.61
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FLGB, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 36.04, equal to the 50-day MA of 35.61, and equal to the 200-day MA of 33.24, indicating a neutral trend. The MACD of 0.10 indicates Positive momentum. The RSI at 42.55 is Neutral, neither overbought nor oversold. The STOCH value of 6.61 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FLGB.

FLGB Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$848.34M0.09%
72
Outperform
$3.46B0.50%
72
Outperform
$751.83M0.45%
64
Neutral
$722.09M0.07%
63
Neutral
$42.72M0.59%
67
Neutral
$40.06M0.80%
69
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FLGB
Franklin FTSE United Kingdom ETF
35.13
7.04
25.06%
EWU
iShares MSCI United Kingdom ETF
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
SPEU
SPDR Portfolio Europe ETF
EWUS
iShares MSCI United Kingdom Small Cap ETF
FKU
First Trust United Kingdom AlphaDEX Fund
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement